Peptide record

TPDB05663

Antibacterial Toxicity standard
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05663
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 8-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
RRRWWWWA
Physicochemical Analysis
C65H83N21O9
NDCEQGHILKMFPSTYV
W
1302.51
12.70
3
0
5
+3
-5.14
-1.912
12.50
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
22000
1689.05
0
Residue Composition
number
1
A
3
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
4
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 4 Y: 0 V: 0
Chemical Descriptors
8
C65H83N21O9
1302.51
12.70
+3
-5.14
-1.912
Evidence Records 3 records
Evidence 1 Activity

Activity

MIC
Antibacterial
12.5 µM

Target

Staphylococcus aureus M838-17

Source & Reference

NA

Other

active against S. aureus M838-17 (MIC 12.5 uM), P. aeruginosa E411-17 (MIC 25 uM), and K-pneumoniae E406-17 (MIC >50 uM).
Evidence 2 Activity

Activity

MIC
Antibacterial
25 µM

Target

Pseudomonas aeruginosa E411-17

Source & Reference

NA

Other

active against S. aureus M838-17 (MIC 12.5 uM), P. aeruginosa E411-17 (MIC 25 uM), and K-pneumoniae E406-17 (MIC >50 uM).
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
>200 µM
Hemolytic Cytotoxic
50% Hemolysis | >200 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Two distinct amphipathic peptide antibiotics with systemic efficacy. | Proc Natl Acad Sci U S A | 2020